TW200613307A - 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones - Google Patents

4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones

Info

Publication number
TW200613307A
TW200613307A TW094116033A TW94116033A TW200613307A TW 200613307 A TW200613307 A TW 200613307A TW 094116033 A TW094116033 A TW 094116033A TW 94116033 A TW94116033 A TW 94116033A TW 200613307 A TW200613307 A TW 200613307A
Authority
TW
Taiwan
Prior art keywords
substituted
methanimidamidyl
arylc1
6alkyloxy
6alkyl
Prior art date
Application number
TW094116033A
Other languages
English (en)
Inventor
Bart Rudolf Romanie Kesteleyn
De Vreken Wim Van
Sandrine Marie Helene Vendeville
Pierre Jean-Marie Raboisson
Dominique Louis Nestor Ghislain Surleraux
Piet Tom Bert Paul Wigerinck
Annick Ann Peeters
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of TW200613307A publication Critical patent/TW200613307A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW094116033A 2004-05-17 2005-05-17 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones TW200613307A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04102172 2004-05-17

Publications (1)

Publication Number Publication Date
TW200613307A true TW200613307A (en) 2006-05-01

Family

ID=34929107

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094116033A TW200613307A (en) 2004-05-17 2005-05-17 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones

Country Status (9)

Country Link
US (1) US7622582B2 (zh)
EP (1) EP1751165A1 (zh)
JP (1) JP4879889B2 (zh)
CN (1) CN1953982B (zh)
AR (1) AR052304A1 (zh)
BR (1) BRPI0511267A (zh)
MX (1) MXPA06013315A (zh)
TW (1) TW200613307A (zh)
WO (1) WO2005111044A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0511264A (pt) * 2004-05-17 2007-11-27 Tibotec Pharm Ltd 1-fenil-1,5-diidro-pirido[3,2-b] indol-2-onas 5-substituìdas e análogos como antivirais
BRPI0709940A2 (pt) 2006-04-03 2011-08-02 Tibotec Pharm Ltd 3,4-diidro-imidazo[4,5-b]piridin-5-onas para inibição do hiv
WO2008037783A1 (en) * 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
EP2097416B1 (en) 2006-12-18 2012-09-12 Amgen, Inc Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AU2007334323B2 (en) 2006-12-18 2011-03-10 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AU2008241577B2 (en) 2007-04-18 2011-04-07 Amgen Inc. Indanone derivatives that inhibit prolyl hydroxylase
WO2008130600A2 (en) 2007-04-18 2008-10-30 Amgen Inc. Quinolones and azaquinolones that inhibit prolyl hydroxylase
WO2008137060A1 (en) 2007-05-04 2008-11-13 Amgen Inc. Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
EP2155746A2 (en) 2007-05-04 2010-02-24 Amgen, Inc Diazaquinolones that inhibit prolyl hydroxylase activity
MX2011001090A (es) * 2008-07-28 2011-03-15 Gilead Sciences Inc Compuestos de inhibidor de desacetilasa de histona de cicloalquilideno y heterocicloalquilideno.
JP5643290B2 (ja) 2009-04-09 2014-12-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｈｉｖ複製の阻害薬
WO2015088564A1 (en) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds
WO2015088565A1 (en) * 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds and methods of use thereof
TW201636329A (zh) 2015-02-02 2016-10-16 佛瑪治療公司 作為ｈｄａｃ抑制劑之雙環［４，６，０］異羥肟酸
EA201792673A1 (ru) 2015-02-02 2018-04-30 Форма Терапьютикс, Инк. 3-арил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IL111080A (en) 1993-10-01 1999-08-17 Astra Ab Method for treating a finely divided powder medicament
CN1165291C (zh) 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
HU224217B1 (hu) 1997-03-26 2005-06-28 Janssen Pharmaceutica N.V. Gombaellenes hatóanyaggal és polimerrel bevont magrészt tartalmazó pelletek
NZ508297A (en) * 1998-04-27 2002-12-20 Centre Nat Rech Scient 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases
AU2002246659A1 (en) 2000-12-18 2002-08-06 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
WO2002055520A2 (en) 2000-12-18 2002-07-18 Us Health Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AP1927A (en) 2002-11-15 2008-12-10 Tibotec Pharm Ltd Substituted indolepyridinium as anti-infective compounds

Also Published As

Publication number Publication date
JP4879889B2 (ja) 2012-02-22
US20070213320A1 (en) 2007-09-13
CN1953982B (zh) 2011-07-06
WO2005111044A1 (en) 2005-11-24
AR052304A1 (es) 2007-03-14
US7622582B2 (en) 2009-11-24
MXPA06013315A (es) 2007-02-02
CN1953982A (zh) 2007-04-25
EP1751165A1 (en) 2007-02-14
BRPI0511267A (pt) 2007-11-27
JP2007538052A (ja) 2007-12-27

Similar Documents

Publication Publication Date Title
TW200613307A (en) 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
TW200607503A (en) 1-heterocyclyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
TW200607502A (en) 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
HK1161250A1 (en) Heterocyclic inhibitors of mek and methods of use thereof mek
NZ599815A (en) N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
HRP20130523T1 (en) Fused thiazole derivatives as kinase inhibitors
NZ590266A (en) Protein kinase inhibitors based on dihydro-5h-pyrimido[4,5-b]diazepin or dihydropteridin
TW200745117A (en) Macrocylic inhibitors of hepatitis C virus
EP2308877A4 (en) Imidazopyridine-2-ON DERIVATIVE
RS53075B (en) 1,2,4-TRIAZOLO [4,3-A] PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
WO2005060972A3 (en) Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
MY139923A (en) Macrocylic inhibitors of hepatitis c virus
MX2009006408A (es) Derivados de acidos amino-nicotinicos y amino-isonicotinico como inhibidores de dihidroorotato-deshidrogenasa.
HK1040997A1 (en) Phenylphenanthridines with pde-iv inhibiting activity
GB0508471D0 (en) Therapeutic agents
GEP20125415B (en) Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
NZ592168A (en) Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
PH12019501391A1 (en) Novel compound and pharmacologically acceptable salt thereof
GB1175693A (en) Method for Protecting Plants from Fungi and Compositions therefor
CY1113535T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
MX2023000580A (es) Derivados de 7-(piperidin-1-il)-4h-pirimido[1,2-b]piridazin-4-ona como moduladores alostericos positivos del receptor muscarinico m4 de la acetilcolina.
TW200612933A (en) 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones and analogs
AR043951A1 (es) Compuestos de benzopirano y composiciones farmaceuticas que lo contienen para uso en el tratamiento y la prevencion de afecciones relacionadas con la inflamacion.
NZ314406A (en) Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
EP1486500A4 (en) EFFECTIVE 10- (3-CYCLOPROPYLAMINOMETHYL-1-PYRROLIDINYL) PYRIDOBENZOXAZINECARBOXYLIC ACID DERIVATIVE AGAINST RESISTANT BACTERIA